Our Practice
OTC Markets Compliance
An OTC company must provide timely, accurate, and sufficiently comprehensive information under the framework applicable to its reporting status and market tier.
Capital Markets Law Group assists OTC-traded companies with tier placement, Rule 15c2-11 quotations, Rule 15c2-11 maintenance, disclosure obligations, SEC reporting status, and the path from OTC to a Nasdaq or NYSE American listing. The firm handles OTC matters as part of a broader capital markets practice, so the advice accounts for where the company wants to be in a year or two, not only what it needs this quarter.
What Reporting Status Applies?
An issuer's obligations depend on its reporting framework:
- SEC reporting via Exchange Act Section 12(g) registration
- SEC reporting as a Section 15(d) filer after a registered offering
- Bank reporting
- Alternative reporting approved by OTC Markets
The framework controls both what the company publishes and who accepts it. A company that is subject to SEC reporting must file its statements with the SEC, and OTC Markets links to those filings. A company that reports under an alternative framework publishes through OTC Markets' own disclosure platform. The two tracks are not interchangeable, and moving between them generally does not eliminate obligations the issuer already carries.
What Tier Is the Company In?
OTC Markets groups issuers into tiers with different eligibility and disclosure standards. The tier a company qualifies for depends on its reporting status, audit status, financial history, and qualification matters. Recurring issues include:
- Delinquent or unaudited financial statements that limit tier eligibility
- Shell status or prior shell status that requires waiting periods
- Failed qualification requirements for certain issuers
- Disclosure submitted late or incomplete
The company should confirm the current standards for its situation with counsel and the market itself, since the requirements are published by OTC Markets and change periodically.
What Does Rule 15c2-11 Require?
Rule 15c2-11 is an SEC rule that governs how broker-dealers initiate and maintain quotations. Before publishing a quotation, a broker must review specified information about the issuer. After initiation, the rule requires current information on a continuing basis, with own-account quotations subject to specific timing rules when information lapses.
For OTC issuers, this rule is the link between disclosure work and market status: quotations depend on current information, and lapses in information can affect the market's willingness to display them. Capital Markets Law Group handles both the issuer-side obligations and the market-maker coordination that sits on top of them.
When Should Counsel Become Involved?
Before the company submits disclosure to the market. The common failure patterns happen when companies treat disclosure as a form rather than a legal filing, so a late decision narrows the options. Counsel review before disclosure covers:
- Determining which reporting framework controls the issuer's obligations
- Setting the disclosure timeline consistent with the company's reporting requirements
- Drafting and reviewing the company's annual, quarterly, and other periodic disclosures
- Planning tier placement and the standards each tier requires
- Coordinating transfer agent, DTC, and capitalization issues that surface alongside market eligibility
What Commonly Causes Problems?
Recurring issues in OTC compliance matters include:
- Disclosure submitted after the market's deadlines for the applicable tier
- Statements that do not match the issuer's actual reporting framework
- Delinquent SEC filings left unaddressed while the company reports elsewhere
- Audited financial statements that fail to meet tier audit standards
- Shell-status waiting periods ignored after a reverse merger
- Assumptions that current information status makes shares freely tradable
What Alternatives Are Available?
The main structural choice is between staying on OTC and pursuing a Nasdaq or NYSE American listing. A company that wants an exchange listing will need to satisfy the exchange's requirements, which are stricter than OTC's. Reg D and Reg A exemptions can also determine the kind of offering and disclosure the issuer can use while OTC-traded.
How Does Capital Markets Law Group Help?
Our services may include:
- Confirming the controlling reporting framework
- Planning the disclosure timeline
- Drafting and reviewing periodic disclosures
- Planning tier placement and re-qualification
- Coordinating Rule 15c2-11 issues with sponsoring market makers
- Coordinating transfer agent, DTC, and capitalization matters
- Advising on Reg D, Reg A, and other exemption choices
- Advising on the path to a Nasdaq or NYSE American listing
Keep Reading: Take the Nasdaq Readiness Scorecard · Nasdaq and NYSE American Uplistings, Nasdaq Listing Applications and Uplisting Counsel, SEC Securities Offerings, Going Public and Form S-1 Registration Statements.
Frequently Asked Questions
Does OTC Markets Approve an Issuer's Disclosure?
OTC Markets may review information for compliance with its standards. The issuer remains responsible for accuracy and completeness.
Does Current Status Guarantee Active Trading?
No. Trading depends on broker-dealers, liquidity, investor interest, and market conditions.
Can a Delinquent SEC Filer Switch to Alternative Reporting?
A company generally cannot avoid existing SEC reporting obligations by publishing alternative disclosure.
How Quickly Can a Company Become Current?
Timing depends on the missing reports, audit status, records, corporate history, and management responsiveness.
Does Current OTC Status Make the Shares Freely Tradable?
No. Current information status is separate from each holder's resale analysis. Restricted shares still require Rule 144, a resale registration, or another exemption, and affiliates remain subject to volume and manner-of-sale limits.
What Is the Difference Between OTC Markets Tiers?
OTC Markets operates market tiers with different disclosure and eligibility standards, and the applicable tier depends on the issuer's reporting framework and qualification status. The specific tier requirements are published by OTC Markets, and the company should verify the current standards for its situation with its counsel and the market itself.
Can the Company Use OTC Disclosure Instead of SEC Reporting?
Only where the company's status permits it. A company that is subject to SEC reporting must satisfy those obligations, and alternative disclosure does not substitute for them.
Get Started
Talk to Capital Markets Law Group About OTC Compliance
Capital Markets Law Group assists OTC issuers with disclosure, delinquent reporting, corporate actions, financing, quotation eligibility, and continuing compliance. Contact the firm with the company's current reporting pathway and any deadlines approaching.